Nicca Chemical Co., Ltd.TSE: 4463

Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year 2025(Based on Japanese GAAP)

· Issued by Nicca Chemical Co., Ltd.

Translation

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year 2025(Based on Japanese GAAP)

October 31, 2025

Company name: NICCA CHEMICAL CO., ltd.

Stock exchange listings: Tokyo Stock Exchange

Stock code: 4463

URL: https://www.nicca.co.jp

Representative: Yasuaki Emori, President and Representative Director

Contact: Shoya Sawazaki, Director, Executive Officer, Head of Administration Division

TEL: +81 776-24-0213

Scheduled date for dividend payment:

Supplementary materials for financial summaries:

Yes

Financial results briefing: None

(Amounts of less than one million yen are rounded down.)

  1. Consolidated Financial Results for the Nine Months of the Fiscal Year Ending December 31, 2025 (from January 01, 2025 to September 30, 2025)
    1. Consolidated operating results (Cumulative) (Percentage indicate YoY changes)

      Revenue

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Nine months ended

      Million yen

      %

      Million yen

      %

      Million yen

      %

      Million yen

      %

      September 30, 2025

      41,217

      4.4

      2,901

      15.7

      2,759

      (2.8)

      1,613

      (12.7)

      September 30, 2024

      39,476

      5.4

      2,508

      88.6

      2,839

      56.3

      1,848

      81.6

      (Note) Comprehensive income For the nine months ended December 31, 2025: 766 million yen ((66.0) %) For the nine months ended December 31, 2024: 2,253 million yen ((17.3) %)

      Basic earnings per share

      Diluted earnings per share

      Nine months ended

      Yen

      Yen

      September 30, 2025

      101.76

      -

      September 30, 2024

      116.89

      -

    2. Consolidated financial positions

      Total assets

      Equity

      Equity to total assets ratio

      Net assets per share

      As of

      Million yen

      Million yen

      %

      Yen

      September 30, 2025

      66,489

      36,411

      50.2

      2,098.47

      December 31, 2024

      62,366

      36,553

      54.0

      2,125.60

      (Reference) Owner's equity As of the third quarter of the fiscal year ending December 2025: 33,396 million yen As of the fiscal year ended December 2024: 33,650 million yen

  2. Cash dividends

    Annual dividends per share

    End of first quarter

    End of second quarter

    End of the third quarter

    Fiscal year-end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Fiscal year ended

    December 31, 2024

    -

    25.00

    -

    27.00

    52.00

    Fiscal year ending December 31, 2025

    -

    30.00

    -

    Fiscal year ending December 31, 2025 (Forecast)

    30.00

    60.00

    (Note) Presence or absence of revisions from the most recently announced dividend forecast: None

  3. Consolidated Earnings Forecasts for the Fiscal Year Ending December 31, 2025 (from January 01, 2025 to December 31,
2025)

(Percentages indicate YoY changes)

Revenue

Operating profit

Ordinary profit

Profit attributable to owners of parent

Basic earnings per share

Fiscal year ending December 31, 2025

Million

yen

%

Million

yen

%

Million

yen

%

Million

yen

%

Yen

57,000

5.4

3,600

2.3

3,400

(14.5)

2,400

(12.9)

151.49

(Note) Correction of financial forecast from the most recent financial forecast: None

  • Notes

    1. Significant changes in the scope of consolidation during the period: None

    2. Applying of specific accounting of the consolidated quarterly financial statements: Yes

    3. Changes in accounting policies, changes in accounting estimates, retrospective restatement

      1. Changes in accounting policies due to revisions of accounting standards : None

      2. Changes in accounting policies other than (i): None

      3. Changes in accounting estimates : None

      4. Retrospective restatement : None

    4. Number of shares issued (common stock)

  1. Total number of issued shares at the end of the period (including treasury shares)

    As of September 30, 2025

    17,710,000 shares

    As of December 31, 2024

    17,710,000 shares

  2. Number of treasury shares at the end of the period

    As of September 30, 2025

    1,795,367 shares

    As of December 31, 2024

    1,879,105 shares

  3. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

Nine months ended September 30, 2025

15,852,078 shares

Nine months ended September 30, 2024

15,813,750 shares

※ Review of attached consolidated quarterly financial statements by a certified public accountant or an audit firm: None

Note: Explanation regarding the appropriate use of forecasts and other special notes (Cautionary Statement Regarding Forward-Looking Statements)

The forward-looking statements, including earnings forecasts, contained in this document are based on information currently available to the Company and on certain assumptions deemed reasonable. They are not intended as a guarantee of achievement. Actual results may differ significantly due to various factors in the future.

  • Table of Contents for Attached Materials

  1. Overview of operating results, etc. 2

    1. Overview of operating results for the quarter 2

    2. Overview of financial positions for the quarter 3

    3. Explanation regarding forward-looking statements such as consolidated forecasts 3

  2. Quarterly Consolidated Financial Statements and Main Notes 4

    1. Quarterly Consolidated Balance Sheet 4

    2. Quarterly Consolidated Statement of Income and Quarterly Consolidated Statement of Comprehensive Income 6

    3. Notes to the quarterly consolidated financial statements 8

(Notes on specific accounting treatments for the preparation of quarterly consolidated financial statements) 8

(Notes on segment information, etc.) 9

(Notes on significant changes in the amount of shareholders' equity) 11

(Notes regarding the assumption of a going concern) 11

(Notes on quarterly consolidated statement of cash flows) 11

  1. Overview of Operating Results, etc.

    1. Overview of operating results for the quarter

      For the nine months ended September 30, 2025, the global economy continued to face instability due to persistently high geopolitical risks surrounding the situations in Ukraine and the Middle East, as well as fluctuations in crude oil and resource prices. In addition, the outlook for the global economy remained uncertain, reflecting the impact of protectionist policies such as reciprocal tariffs under the Trump administration in the United States, as well as trends in monetary policy and exchange rate fluctuations in major countries. On the other hand, the Japanese economy maintained a moderate recovery trend, supported by a rebound in personal consumption and a recovery in inbound demand. However, concerns about a slowdown in overseas economies and the impact of U.S. tariff policies have left uncertainty regarding the future outlook.

      Under these circumstances, our group has established the corporate purpose of "Activate Your Life" (to solve various social issues together with stakeholders through the infinite potential of interface chemistry, thereby contributing to a richer life and a brighter future). Based on this purpose and our medium- to long-term growth vision of becoming 'the most trusted innovation company by customers worldwide,' we have formulated the three-year medium-term management plan 'INNOVATION25' (2023-2025). Currently, we are working to promote the five key strategies of the medium-term management plan: 'drastic business structure transformation,' 'focused investment,' 'productivity reform,' 'promotion of sustainable management,' and 'evolution of the big family principle.'

      We will continue to transform the rapidly changing business environment into business opportunities, focus on businesses that provide increasingly essential value to society, and strive for sustainable growth.

      For the nine months ended September 30, 2025, which is the final year of the three-year medium-term management plan 'INNOVATION25', net sales were 41,217 million yen (up 4.4% YoY), operating profit was 2,901 million yen (up 15.7% YoY), ordinary profit was 2,759 million yen (down 2.8% YoY), and profit attributable to owners of parent was 1,613 million yen (down 12.7% YoY).

      The performance of each segment is as follows. Note that the Net sales of each segment mentioned in the text do not include internal Net sales between segments.

      (Chemicals Business)

      Net sales were 29,475 million yen (up 1.3% YoY), and segment profit was 2,979 million yen (up 5.9% YoY).

      In our core textile chemicals business, the operation of overseas textile processing plants, which are our customers, slowed down due to the impact of the Trump tariffs. However, sales increased, particularly at our China base, driven by growth in high value-added EHD-related finished goods such as fluorine-free water repellents and process rationalization agents, as well as the acquisition of new business. In addition, sales of electronic materials-related process chemicals also increased due to a partial recovery in the semiconductor market and the acquisition of new business.

      Although selling, general and administrative expenses increased due to the growth in these sales, the chemicals business recorded both higher revenue and profit.

      (Cosmetics Business)

      Net sales were 11,344 million yen (up 11.7% YoY), and segment profit was 1,430 million yen (up 24.0% YoY).

      At our company, Demicosmetics, despite the continued uncertainty in the domestic economy due to factors such as rising prices and the challenging salon environment caused by a decrease in customer visits due to the extreme heat, we maintained steady performance through the expansion of our main hair care products and new merchandise. Among consolidated subsidiaries, although sales at DEMI KOREA CO., LTD. declined due to deteriorating market conditions, the contract business at Yamada Pharmaceutical Co., Ltd. performed well.

      As a result, the cosmetics business recorded increases in both revenue and profit. (Others)

      Net sales were 397 million yen (up 68.9% YoY), and segment profit was 50 million yen (compared to a segment loss of 5 million yen in the same period of the previous year).

    2. Overview of financial positions for the quarter ( Assets)

      As for the total assets at the end of the third quarter of the consolidated fiscal period, they increased by 4,123 million yen compared to the end of the previous consolidated fiscal year, reaching 66,489 million yen. The main factors for this were a decrease of 1,216 million yen in notes and accounts receivable - trade, and contract assets, while cash and deposits increased by 607 million yen, and other (net) in property, plant and equipment increased by 4,791 million yen.

      ( Liabilities)

      As for the total liabilities at the end of the third quarter of the consolidated fiscal period, it increased by 4,265 million yen compared to the end of the previous consolidated fiscal year, reaching 30,078 million yen. The main reasons for this were an increase of 3,192 million yen in short-term borrowings and an increase of 724 million yen in long-term borrowings.

      ( Net assets)

      As for the total net assets at the end of the third quarter of the consolidated fiscal period, it decreased by 142 million yen compared to the end of the previous consolidated fiscal year, amounting to 36,411 million yen. The main factors for this were an increase in retained earnings by 709 million yen, while foreign currency translation adjustment decreased by 665 million yen and remeasurements of defined benefit plans decreased by 472 million yen.

    3. Explanation regarding consolidated forecasts and other forward-looking statements

      No revisions have been made to the consolidated forecasts announced on July 31, 2025.

  2. Quarterly Consolidated Financial Statements and Main Notes (1) Quarterly Consolidated Balance Sheet

(Unit: Million yen)

Previous fiscal year (December 31, 2024)

For the third quarter (September 30, 2025)

Assets

Current assets

Cash and deposit

10,726

11,334

Notes and accounts receivable - trade, and contract assets

11,996

10,780

Merchandise and finished goods

5,314

5,410

Work in process

818

904

Raw materials and supplies

4,372

4,494

Others

1,005

1,144

Allowance for doubtful accounts

(13)

(13)

Total current asset

34,221

34,057

Non-current assets

Property, plant, and equipment

Buildings and structures, net

12,401

11,733

Machinery, equipment and vehicles, net

2,365

2,057

Land

7,760

7,768

Other (net)

1,475

6,266

Total property, plant and equipment, net

24,002

27,826

Intangible assets

Other

510

827

Total intangible assets

510

827

Investment Other assets

Other

3,631

3,778

Total investment and other assets

3,631

3,778

Total non-current assets

28,144

32,432

Total assets

62,366

66,489

(Unit: Million yen)

Previous fiscal year (December 31, 2024)

For the third quarter (September 30, 2025)

Liabilities

Current liabilities

Notes and accounts payable - trade

6,181

6,038

Short-term borrowings

4,300

7,492

Current portion of long-term borrowings

1,368

1,368

Income taxes payable

534

366

Provision for bonuses

961

618

Provision for bonuses for directors

15

14

Other

3,783

4,440

Total current liabilities

17,143

20,339

Non-current liabilities

Long-term borrowings

4,234

4,958

Liabilities for retirement benefits

3,132

3,263

Provision for share-based payments

210

224

Other

1,091

1,292

Total non-current liabilities

8,668

9,738

Total liabilities

25,812

30,078

Net assets

Shareholders' equity

Share capital

2,898

2,898

Capital surplus

2,960

2,991

Retained earnings

24,251

24,961

Treasury shares

(1,407)

(1,342)

Total shareholders' equity

28,703

29,509

Accumulated other comprehensive income

Valuation difference on available-for-sale securities

719

798

Foreign currency translation adjustment

4,119

3,453

Remeasurements of defined benefit plans

107

(365)

Total accumulated other comprehensive income

4,946

3,887

Non-controlling interests

2,903

3,015

Total net assets

36,553

36,411

Total liabilities and net assets

62,366

66,489

  1. Quarterly Consolidated Statement of Income and Quarterly Consolidated Statement of Comprehensive Income (Quarterly Consolidated Statement of Income)

    (Nine months ended)

    (Unit: Million yen)

    For the nine months ended [previous period end date] From January 1, 2024

    until September 30, 2024

    For the nine months ended From January 1, 2025

    until September 30, 2025

    Revenue

    39,476

    41,217

    Cost of sales

    25,357

    26,347

    Gross profit

    14,119

    14,870

    Selling, general and administrative expenses

    11,610

    11,969

    Operating profit

    2,508

    2,901

    Non-operating income

    Interest income

    55

    80

    Dividend income

    24

    30

    Share of income of investments accounted for using the equity method

    12

    15

    Foreign exchange gains

    51

    -

    Other

    238

    132

    Total non-operating income

    382

    259

    Non-operating expenses

    Interest expense

    29

    84

    Foreign exchange losses

    -

    137

    Commission expenses

    -

    141

    Other

    22

    38

    Total non-operating expenses

    51

    401

    Ordinary profit

    2,839

    2,759

    Extraordinary income

    Gain on sale of non-current assets

    2

    135

    Total extraordinary income

    2

    135

    Extraordinary losses

    Loss on retirement of fixed assets

    4

    3

    Loss on sale of non-current assets

    0

    0

    Loss on sale of investment securities

    0

    -

    Total extraordinary losses

    4

    3

    Net income before income taxes

    2,837

    2,890

    Income taxes

    769

    1,024

    Net income

    2,067

    1,866

    Net income attributable to non-controlling interests

    219

    253

    Profit attributable to owners of parent

    1,848

    1,613

    (Quarterly Consolidated Statement of Comprehensive Income) (Nine months ended)

    (Unit: Million yen)

    For the nine months ended [previous period end date] From January 1, 2024

    until September 30, 2024

    For the nine months ended From January 1, 2025

    until September 30, 2025

    Net income

    2,067

    1,866

    Other comprehensive income (loss), net of tax

    Valuation difference on available-for-sale securities

    81

    79

    Foreign currency translation adjustment

    78

    (707)

    Remeasurements of defined benefit plans, net of tax

    26

    (471)

    Other comprehensive income, net of tax

    186

    (1,100)

    Comprehensive income

    2,253

    766

    Comprehensive income attributable to

    Quarterly comprehensive income attributable to owners of the parent

    1,982

    553

    Quarterly comprehensive income attributable to non-controlling interests

    270

    213

  2. Notes to the quarterly consolidated financial statements

    (Notes on accounting treatments specific to the preparation of quarterly consolidated financial statements) (Calculation of tax expenses)

    For income tax expenses, the effective tax rate after applying tax effect accounting, reasonably estimated for the fiscal year including the third quarter of the current consolidated fiscal period, is applied to pre-tax Net income to calculate the tax expense. However, if calculating tax expenses using the estimated effective tax rate results in a significantly unreasonable outcome, the statutory effective tax rate is used instead.

    (Notes on segment information, etc.)

    I Previous nine months ended September 30, 2024

    1. Information on net sales and profit or loss by reportable segment

      (Unit: Million yen)

      Reportable segment

      Other (Note)

      Total

      Chemicals

      Cosmetics

      Total

      Revenue

      Net sales to external customers

      29,083

      10,157

      39,241

      235

      39,476

      Internal net sales between segments or transfer amount

      -

      1

      1

      169

      170

      Total

      29,083

      10,158

      39,242

      405

      39,647

      Segment profit or loss (-)

      2,813

      1,153

      3,967

      (5)

      3,961

      (Note) The category of "Others" refers to business segments not included in the reportable segments, and includes equipment contract work.

    2. Difference between the total amount of profit or loss of reportable segments and the amount recorded in the quarterly consolidated statement of income, and the main contents of such difference (matters related to reconciliation of differences)

      (Unit: Million yen)

      Profit

      Amount

      Total for reportable segments

      3,967

      Profit or loss (-) in the "Others" category

      (5)

      Elimination of inter-segment transactions

      25

      Corporate expenses (Note)

      (1,477)

      Operating profit in the quarterly consolidated statement of income

      2,508

      (Note) Company-wide expenses mainly consist of general and administrative expenses that are not attributable to any reportable segment.

    3. Information on impairment losses of non-current assets or goodwill, etc. by reportable segment (Significant impairment losses related to non-current assets)

There are no applicable items.

(Significant changes in the amount of goodwill) There are no applicable items.

(Significant gain on bargain purchase) There are no applicable matters.

II For the nine months ended September 30, 2025

  1. Information on net sales and profit or loss by reportable segment

    (Unit: Million yen)

    Reportable segment

    Other (Note)

    Total

    Chemicals

    Cosmetics

    Total

    Revenue

    Net sales to external customers

    29,475

    11,344

    40,819

    397

    41,217

    Internal net sales between segments or transfer amount

    1

    3

    4

    158

    163

    Total

    29,477

    11,347

    40,824

    555

    41,380

    Segment profit or loss (-)

    2,979

    1,430

    4,409

    50

    4,459

    (Note) The category of "Others" refers to business segments not included in the reportable segments, and includes equipment contracting work.

  2. Difference between the total amount of profit or loss of reportable segments and the amount recorded in the quarterly consolidated statement of income, and the main contents of such difference (matters related to reconciliation of differences)

    (Unit: Million yen)

    Profit

    Amount

    Total for reportable segments

    4,409

    Profit or loss (-) in the "Other" category

    50

    Elimination of inter-segment transactions

    19

    Company-wide expenses (Note)

    (1,577)

    Operating profit in the quarterly consolidated statement of income

    2,901

    (Note) Company-wide expenses mainly consist of general and administrative expenses that are not attributable to any reportable segment.

  3. Information on Impairment losses of Non-current assets or Goodwill, etc. by reportable segment (Significant impairment losses related to non-current assets)

There are no applicable items.

(Significant changes in the amount of goodwill) There are no applicable items.

(Significant gain on bargain purchase) There are no applicable items.

(Notes in case of significant changes in the amount of shareholders' equity) There are no applicable items.

(Notes regarding the assumption of a going concern) There are no applicable items.

(Notes on quarterly consolidated statement of cash flows)

The quarterly consolidated statement of cash flows for the nine months ended September 30 has not been prepared. Depreciation for the nine months ended September 30 (including amortization of intangible assets other than goodwill) is as follows.

For the nine months ended [previous

period end date] (From January 1, 2024

For the nine months ended From January 1, 2025

until September 30, 2025

until September 30, 2024

Depreciation 1,652 million yen 1,578 million yen

Company analysis

Earlier from Nicca Chemical

All Nicca Chemical news releases